https://www.lgog.be/klinische-studies/xmab_ov_zorgverlener-22026-08-28T13:41:41+02:00weekly0.5https://www.lgog.be/klinische-studies/ov97_en_zorgverlener-2-22026-09-23T14:52:48+02:00weekly0.5https://www.lgog.be/klinische-studies/ov93_en_zorgverlener-2-22026-06-19T14:23:19+02:00weekly0.5https://www.lgog.be/klinische-studies/napistar2_en_zorgverlener-2-22026-06-17T11:29:35+02:00weekly0.5https://www.lgog.be/klinische-studies/rad_en_zorgverlener-2-2-22026-03-13T16:32:59+01:00weekly0.5https://www.lgog.be/klinische-studies/ov89_en_zorgverlener2026-03-13T16:33:11+01:00weekly0.5https://www.lgog.be/klinische-studies/ov85_en_zorgverlener-2-22026-06-17T11:46:04+02:00weekly0.5https://www.lgog.be/klinische-studies/nplus_en_zorgverlener-2-2-2-22026-03-13T16:33:30+01:00weekly0.5https://www.lgog.be/klinische-studies/nirvana_en_zorgverlener-2-22026-03-13T16:33:53+01:00weekly0.5https://www.lgog.be/klinische-studies/bgog-ov81_en_zorgverlener-22026-03-13T16:34:04+01:00weekly0.5https://www.lgog.be/klinische-studies/regn4018_en_zorgverlener2026-03-13T16:34:16+01:00weekly0.5https://www.lgog.be/klinische-studies/bgog-ov70-alepro_en_zorgverlener2026-03-13T16:34:33+01:00weekly0.5https://www.lgog.be/klinische-studies/regn5668_en_zorgverlener2026-03-13T16:35:16+01:00weekly0.5https://www.lgog.be/klinische-studies/ov84_en_zorgverlener-2-2-22026-06-05T10:22:51+02:00weekly0.5https://www.lgog.be/klinische-studies/ov96_en_zorgverlener-12026-08-28T12:00:40+02:00weekly0.5https://www.lgog.be/klinische-studies/ov94_ov_zorgverlener-2-22026-03-13T16:41:28+01:00weekly0.5https://www.lgog.be/klinische-studies/florenza1_en_zorgverlener-22026-03-13T16:41:44+01:00weekly0.5https://www.lgog.be/klinische-studies/bella_en_zorgverlener-22026-03-13T16:42:13+01:00weekly0.5https://www.lgog.be/klinische-studies/florenza3_en_zorgverlener-2-22026-08-28T14:18:33+02:00weekly0.5https://www.lgog.be/klinische-studies/223559_ov_zorgverlener-2-22026-09-10T11:52:29+02:00weekly0.5https://www.lgog.be/klinische-studies/napistar_en_zorgverlener2026-10-02T16:06:21+02:00weekly0.5https://www.lgog.be/klinische-studies/denali_en_zorgverlener-22026-06-03T10:30:04+02:00weekly0.5https://www.lgog.be/klinische-studies/imgn8530425_en_zorgverlener-2-2-22026-05-06T09:32:40+02:00weekly0.5https://www.lgog.be/klinische-studies/ds3939_ov_zorgverlener-2-2-2-22025-11-03T13:49:41+01:00weekly0.5https://www.lgog.be/klinische-studies/imgn151_en_zorgverlener-22025-11-03T13:46:22+01:00weekly0.5https://www.lgog.be/klinische-studies/rejoice_ov_zorgverlener-2-2-22025-08-25T14:45:12+02:00weekly0.5https://www.lgog.be/klinische-studies/ov83_ov_zorgverlener-2-2-22026-10-07T16:54:37+02:00weekly0.5https://www.lgog.be/klinische-studies/222730_en_zorgverlener-22026-10-07T16:53:04+02:00weekly0.5https://www.lgog.be/klinische-studies/ov86_ov_zorgverlener-2-22026-02-25T15:19:27+01:00weekly0.5https://www.lgog.be/klinische-studies/bgog-ov67-gloriosa_en_zorgverlener2025-09-08T07:36:02+02:00weekly0.5https://www.lgog.be/klinische-studies/imgn853-0424_en_zorgverlener2025-04-16T14:45:03+02:00weekly0.5https://www.lgog.be/klinische-studies/bgog-ov58-tedova_en_zorgverlener2024-11-18T08:22:33+01:00weekly0.5https://www.lgog.be/klinische-studies/bgog-ov56-dovacc_en_zorgverlener2025-01-20T13:42:35+01:00weekly0.5https://www.lgog.be/klinische-studies/bgogen31_en_zorgverlener2026-06-17T15:33:43+02:00weekly0.5https://www.lgog.be/klinische-studies/bgogen29_en_zorgverlener-22026-06-17T15:21:46+02:00weekly0.5https://www.lgog.be/klinische-studies/en25_en_zorgverlener-2-22026-03-13T16:44:04+01:00weekly0.5https://www.lgog.be/klinische-studies/en24_en_zorgverlener-2-2-22026-03-13T16:45:44+01:00weekly0.5https://www.lgog.be/klinische-studies/en28_en_zorgverlener-2-2-2-22026-09-14T08:57:23+02:00weekly0.5https://www.lgog.be/klinische-studies/bluestar_en_zorgverlener-22026-07-07T09:05:10+02:00weekly0.5https://www.lgog.be/klinische-studies/223559_en_zorgverlener-22026-06-17T15:35:09+02:00weekly0.5https://www.lgog.be/klinische-studies/imgn151-en_en_zorgverlener2026-01-19T08:36:15+01:00weekly0.5https://www.lgog.be/klinische-studies/rejoice_en_zorgverlener-2-2-2-22025-08-25T14:56:35+02:00weekly0.5https://www.lgog.be/klinische-studies/222730en_en_zorgverlener2026-10-07T16:56:58+02:00weekly0.5https://www.lgog.be/klinische-studies/bgog-en20_en_zorgverlener2026-01-19T08:38:38+01:00weekly0.5https://www.lgog.be/klinische-studies/bella_zorgverlener-2-22026-09-04T08:26:56+02:00weekly0.5https://www.lgog.be/klinische-studies/bgog-en23_en_zorgverlener2025-04-11T09:47:51+02:00weekly0.5https://www.lgog.be/klinische-studies/cx22_cx_zorgverlener-22026-03-13T16:49:03+01:00weekly0.5https://www.lgog.be/klinische-studies/rejoice_cx_zorgverlener-2-2-2-2-22025-09-10T08:32:39+02:00weekly0.5https://www.lgog.be/klinische-studies/bgog-cx20_en_zorgverlener-22025-10-02T09:51:20+02:00weekly0.5https://www.lgog.be/klinische-studies/national-registry-for-trophoblast-diseases_zorgverlener2026-06-24T14:18:22+02:00weekly0.5https://www.lgog.be/uploads/images/Studies/Vagina-vulva-trofoblast/Mola.pngMolahttps://www.lgog.be/klinische-studies/vulcanize-zorgverlener-22026-03-13T16:46:43+01:00weekly0.5